Outset Medical Inc (OM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Outset Medical Inc (OM) has a cash flow conversion efficiency ratio of -0.115x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-12.84 Million) by net assets ($111.69 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Outset Medical Inc to measure how much of total assets are equity-financed.
Outset Medical Inc - Cash Flow Conversion Efficiency Trend (2018–2025)
This chart illustrates how Outset Medical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore OM debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Outset Medical Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Outset Medical Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Wittchen SA
WAR:WTN
|
0.113x |
|
Grupo Greening 2022 SA
MC:GGR
|
N/A |
|
SG&G Corporation
KQ:040610
|
0.002x |
|
Spero Therapeutics Inc
NASDAQ:SPRO
|
-0.141x |
|
Mistral Gayrimenkul Yatirim Ortakligi AS
IS:MSGYO
|
-0.005x |
|
Nature and Environment Co. Ltd
KQ:043910
|
-0.061x |
|
Daishin Balance No.6 Special Purpose Acquisition Co. Ltd
KQ:307750
|
0.040x |
|
Maronan Metals Ltd
AU:MMA
|
-0.179x |
Annual Cash Flow Conversion Efficiency for Outset Medical Inc (2018–2025)
The table below shows the annual cash flow conversion efficiency of Outset Medical Inc from 2018 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Outset Medical Inc.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $126.95 Million | $-46.33 Million | -0.365x | +91.59% |
| 2024-12-31 | $26.82 Million | $-116.30 Million | -4.337x | -305.64% |
| 2023-12-31 | $122.89 Million | $-131.37 Million | -1.069x | -80.46% |
| 2022-12-31 | $245.99 Million | $-145.73 Million | -0.592x | -70.13% |
| 2021-12-31 | $374.08 Million | $-130.26 Million | -0.348x | -15.57% |
| 2020-12-31 | $328.61 Million | $-99.02 Million | -0.301x | -259.54% |
| 2019-12-31 | $-372.19 Million | $-70.29 Million | 0.189x | +17.10% |
| 2018-12-31 | $-287.95 Million | $-46.44 Million | 0.161x | -- |
About Outset Medical Inc
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge… Read more